{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:16:22Z","timestamp":1763018182782,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T00:00:00Z","timestamp":1617148800000},"content-version":"am","delay-in-days":364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ygyno.2020.02.021","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T01:02:47Z","timestamp":1583197367000},"page":"131-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Lymph node metastasis probability in young patients eligible for conservative management of endometrial cancer"],"prefix":"10.1016","volume":"157","author":[{"given":"Cl\u00e9mentine","family":"Gonthier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daria","family":"Douhnai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3872-2810","authenticated-orcid":false,"given":"Martin","family":"Koskas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2020.02.021_bb0005","doi-asserted-by":"crossref","unstructured":"R. L. Siegel, K. D. Miller, et A. Jemal, \u00ab Cancer statistics, 2018 \u00bb, CA Cancer J. Clin., vol. 68, no 1, p. 7\u201330, janv. 2018, https:\/\/doi.org\/10.3322\/caac.21442.","DOI":"10.3322\/caac.21442"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0010","doi-asserted-by":"crossref","unstructured":"R. L. Siegel, K. D. Miller, et A. Jemal, \u00ab Cancer statistics, 2015 \u00bb, CA Cancer J. Clin., vol. 65, no 1, p. 5\u201329, f\u00e9vr. 2015, https:\/\/doi.org\/10.3322\/caac.21254.","DOI":"10.3322\/caac.21254"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0015","doi-asserted-by":"crossref","unstructured":"P. Morice, A. Leary, C. Creutzberg, N. Abu-Rustum, et E. Darai, \u00ab Endometrial cancer \u00bb, Lancet Lond. Engl., vol. 387, no 10023, p. 1094\u20131108, mars 2016, https:\/\/doi.org\/10.1016\/S0140-6736(15)00130-0.","DOI":"10.1016\/S0140-6736(15)00130-0"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0020","doi-asserted-by":"crossref","unstructured":"D. Querleu et al., \u00ab [Primary management of endometrial carcinoma. Joint recommendations of the French society of gynecologic oncology (SFOG) and of the French college of obstetricians and gynecologists (CNGOF)] \u00bb, Gynecol. Obstet. Fertil. Senol., vol. 45, no 12, p. 715\u2013725, d\u00e9c. 2017, https:\/\/doi.org\/10.1016\/j.gofs.2017.10.008.","DOI":"10.1016\/j.gofs.2017.10.008"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0025","doi-asserted-by":"crossref","unstructured":"M. Koskas, J. Uzan, D. Luton, R. Rouzier, et E. Dara\u00ef, \u00ab Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis \u00bb, Fertil. Steril., vol. 101, no 3, p. 785\u2013794, mars 2014, https:\/\/doi.org\/10.1016\/j.fertnstert.2013.11.028.","DOI":"10.1016\/j.fertnstert.2013.11.028"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.gore.2017.08.001","article-title":"Dual progestin therapy for fertility-sparing treatment of grade 2 endometrial adenocarcinoma","volume":"21","author":"Newtson","year":"2017","journal-title":"Gynecol. Oncol. Rep."},{"key":"10.1016\/j.ygyno.2020.02.021_bb0035","doi-asserted-by":"crossref","unstructured":"J.-Y. Park et al., \u00ab Hormonal therapy for women with stage IA endometrial cancer of all grades \u00bb, Obstet. Gynecol., vol. 122, no 1, p. 7\u201314, juill. 2013, https:\/\/doi.org\/10.1097\/AOG.0b013e3182964ce3.","DOI":"10.1097\/AOG.0b013e3182964ce3"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0040","doi-asserted-by":"crossref","unstructured":"A. S. El-Agwany et M. H. Meleis, \u00ab Value and best way for detection of Sentinel lymph node in early stage endometrial cancer: selective lymphadenectomy algorithm \u00bb, Eur. J. Obstet. Gynecol. Reprod. Biol., vol. 225, p. 35\u201339, mars 2018, https:\/\/doi.org\/10.1016\/j.ejogrb.2018.03.042.","DOI":"10.1016\/j.ejogrb.2018.03.042"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0045","doi-asserted-by":"crossref","unstructured":"M. Ballester, S. Bendifallah, et E. Dara\u00ef, \u00ab [European guidelines (ESMO-ESGO-ESTRO consensus conference) for the management of endometrial cancer] \u00bb, Bull. Cancer (Paris), vol. 104, no 12, p. 1032\u20131038, d\u00e9c. 2017, https:\/\/doi.org\/10.1016\/j.bulcan.2017.10.006.","DOI":"10.1016\/j.bulcan.2017.10.006"},{"issue":"Suppl. 6","key":"10.1016\/j.ygyno.2020.02.021_bb0050","doi-asserted-by":"crossref","first-page":"vi33","DOI":"10.1093\/annonc\/mdt353","article-title":"Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Colombo","year":"2013","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.ygyno.2020.02.021_bb0055","doi-asserted-by":"crossref","unstructured":"M. Ballester et al., \u00ab Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO) \u00bb, Lancet Oncol., vol. 12, no 5, p. 469\u2013476, mai 2011, https:\/\/doi.org\/10.1016\/S1470-2045(11)70070-5.","DOI":"10.1016\/S1470-2045(11)70070-5"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0060","unstructured":"J. C. Schink, J. R. Lurain, C. B. Wallemark, et J. S. Chmiel, \u00ab Tumor size in endometrial cancer: a prognostic factor for lymph node metastasis \u00bb, Obstet. Gynecol., vol. 70, no 2, p. 216\u2013219, ao\u00fbt 1987."},{"key":"10.1016\/j.ygyno.2020.02.021_bb0065","doi-asserted-by":"crossref","unstructured":"G. Canlorbe et al., \u00ab Tumor size, an additional prognostic factor to include in low-risk endometrial cancer: results of a French multicenter study \u00bb, Ann. Surg. Oncol., vol. 23, no 1, p. 171\u2013177, janv. 2016, https:\/\/doi.org\/10.1245\/s10434-015-4583-3.","DOI":"10.1245\/s10434-015-4583-3"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0070","doi-asserted-by":"crossref","unstructured":"M. Frumovitz et al., \u00ab Predictors of final histology in patients with endometrial cancer \u00bb, Gynecol. Oncol., vol. 95, no 3, p. 463\u2013468, d\u00e9c. 2004, https:\/\/doi.org\/10.1016\/j.ygyno.2004.07.016.","DOI":"10.1016\/j.ygyno.2004.07.016"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0075","doi-asserted-by":"crossref","unstructured":"J.-L. Brun, L. Ouldamer, N. Bourdel, C. Huchon, M. Koskas, et T. Gauthier, \u00ab Management of Stage I Endometrial Cancer in France: a survey on current practice \u00bb, Ann. Surg. Oncol., vol. 22, no 7, p. 2395\u20132400, juill. 2015, https:\/\/doi.org\/10.1245\/s10434-014-4262-9.","DOI":"10.1245\/s10434-014-4262-9"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0080","article-title":"The diagnostic value of MRI for preoperative staging in patients with endometrial cancer: a meta-analysis","author":"Bi","year":"2019","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.ygyno.2020.02.021_bb0085","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1186\/1471-2407-10-465","article-title":"Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy?","volume":"10","author":"Ballester","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0090","doi-asserted-by":"crossref","unstructured":"S. Sato et al., \u00ab Preoperative and intraoperative assessments of depth of myometrial invasion in endometrial cancer \u00bb, Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc., vol. 19, no 5, p. 884\u2013887, juill. 2009, https:\/\/doi.org\/10.1111\/IGC.0b013e3181a7a2d9.","DOI":"10.1111\/IGC.0b013e3181a7a2d9"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0095","doi-asserted-by":"crossref","unstructured":"D. S. Chi et al., \u00ab The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology \u00bb, Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc., vol. 18, no 2, p. 269\u2013273, avr. 2008, https:\/\/doi.org\/10.1111\/j.1525-1438.2007.00996.x.","DOI":"10.1111\/j.1525-1438.2007.00996.x"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0100","doi-asserted-by":"crossref","unstructured":"M. Zhu et al., \u00ab Whether intermediate-risk stage 1A, grade 1\/2, endometrioid endometrial cancer patients with lesions larger than 2 cm warrant lymph node dissection? \u00bb, BMC Cancer, vol. 17, no 1, p. 696, oct. 2017, https:\/\/doi.org\/10.1186\/s12885-017-3671-0.","DOI":"10.1186\/s12885-017-3671-0"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0105","doi-asserted-by":"crossref","unstructured":"P. Benedetti Panici et al., \u00ab Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial \u00bb, J. Natl. Cancer Inst., vol. 100, no 23, p. 1707\u20131716, d\u00e9c. 2008, https:\/\/doi.org\/10.1093\/jnci\/djn397.","DOI":"10.1093\/jnci\/djn397"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0110","doi-asserted-by":"crossref","unstructured":"ASTEC study group, H. Kitchener, A. M. C. Swart, Q. Qian, C. Amos, et M. K. B. Parmar, \u00ab Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study \u00bb, Lancet Lond. Engl., vol. 373, no 9658, p. 125\u2013136, janv. 2009, https:\/\/doi.org\/10.1016\/S0140-6736(08)61766-3.","DOI":"10.1016\/S0140-6736(08)61766-3"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0115","doi-asserted-by":"crossref","unstructured":"J. A. Frost, K. E. Webster, A. Bryant, et J. Morrison, \u00ab Lymphadenectomy for the management of endometrial cancer \u00bb, Cochrane Database Syst. Rev., vol. 10, p. CD007585, 02 2017, https:\/\/doi.org\/10.1002\/14651858.CD007585.pub4.","DOI":"10.1002\/14651858.CD007585.pub4"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0120","doi-asserted-by":"crossref","unstructured":"M. H. Oonk et al., \u00ab Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study \u00bb, Lancet Oncol., vol. 11, no 7, p. 646\u2013652, juill. 2010, https:\/\/doi.org\/10.1016\/S1470-2045(10)70104-2.","DOI":"10.1016\/S1470-2045(10)70104-2"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0125","doi-asserted-by":"crossref","unstructured":"E. Raimond et al., \u00ab Impact of sentinel lymph node biopsy on the therapeutic management of early-stage endometrial cancer: results of a retrospective multicenter study \u00bb, Gynecol. Oncol., vol. 133, no 3, p. 506\u2013511, juin 2014, https:\/\/doi.org\/10.1016\/j.ygyno.2014.03.019.","DOI":"10.1016\/j.ygyno.2014.03.019"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0130","doi-asserted-by":"crossref","unstructured":"M. Koskas et al., \u00ab Accuracy of a nomogram for prediction of lymph-node metastasis detected with conventional histopathology and ultrastaging in endometrial cancer \u00bb, Br. J. Cancer, vol. 108, no 6, p. 1267\u20131272, avr. 2013, https:\/\/doi.org\/10.1038\/bjc.2013.95.","DOI":"10.1038\/bjc.2013.95"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0135","doi-asserted-by":"crossref","unstructured":"C. H. Kim et al., \u00ab Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasion \u00bb, Gynecol. Oncol., vol. 131, no 3, p. 714\u2013719, d\u00e9c. 2013, https:\/\/doi.org\/10.1016\/j.ygyno.2013.09.027.","DOI":"10.1016\/j.ygyno.2013.09.027"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0140","doi-asserted-by":"crossref","unstructured":"M. Koskas et al., \u00ab Direct comparison of logistic regression and recursive partitioning to predict lymph node metastasis in endometrial cancer \u00bb, Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc., vol. 25, no 6, p. 1037\u20131043, juill. 2015, https:\/\/doi.org\/10.1097\/IGC.0000000000000451.","DOI":"10.1097\/IGC.0000000000000451"},{"year":"2002","series-title":"AJCC Cancer Staging Manual","author":"Greene","key":"10.1016\/j.ygyno.2020.02.021_bb0145"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0150","doi-asserted-by":"crossref","unstructured":"C. Gonthier, A. Trefoux-Bourdet, et M. Koskas, \u00ab Impact of conservative managements in young women with grade 2 or 3 endometrial adenocarcinoma confined to the endometrium \u00bb:, Int. J. Gynecol. Cancer, vol. 27, no 3, p. 493\u2013499, mars 2017, https:\/\/doi.org\/10.1097\/IGC.0000000000000895.","DOI":"10.1097\/IGC.0000000000000895"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0155","doi-asserted-by":"crossref","unstructured":"M. Plante, J. Stanleigh, M.-C. Renaud, A. Sebastianelli, K. Grondin, et J. Gr\u00e9goire, \u00ab Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: does adjuvant treatment matter? \u00bb, Gynecol. Oncol., vol. 146, no 2, p. 240\u2013246, 2017, https:\/\/doi.org\/10.1016\/j.ygyno.2017.05.024.","DOI":"10.1016\/j.ygyno.2017.05.024"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0160","doi-asserted-by":"crossref","unstructured":"C. M. St Clair et al., \u00ab Low-volume lymph node metastasis discovered during sentinel lymph node mapping for endometrial carcinoma \u00bb, Ann. Surg. Oncol., vol. 23, no 5, p. 1653\u20131659, mai 2016, https:\/\/doi.org\/10.1245\/s10434-015-5040-z.","DOI":"10.1245\/s10434-015-5040-z"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0165","doi-asserted-by":"crossref","unstructured":"Y. Todo, H. Kato, K. Okamoto, S. Minobe, K. Yamashiro, et N. Sakuragi, \u00ab Isolated tumor cells and micrometastases in regional lymph nodes in stage I to II endometrial cancer \u00bb, J. Gynecol. Oncol., vol. 27, no 1, p. e1, janv. 2016, https:\/\/doi.org\/10.3802\/jgo.2015.27.e1.","DOI":"10.3802\/jgo.2016.27.e1"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0170","doi-asserted-by":"crossref","unstructured":"R. Vargas et al., \u00ab Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis \u00bb, Gynecol. Oncol., vol. 133, no 2, p. 216\u2013220, mai 2014, https:\/\/doi.org\/10.1016\/j.ygyno.2014.02.011.","DOI":"10.1016\/j.ygyno.2014.02.011"},{"key":"10.1016\/j.ygyno.2020.02.021_bb0175","doi-asserted-by":"crossref","unstructured":"O. Touhami, J. Gr\u00e9goire, M.-C. Renaud, A. Sebastianelli, K. Grondin, et M. Plante, \u00ab The utility of sentinel lymph node mapping in the management of endometrial atypical hyperplasia \u00bb, Gynecol. Oncol., vol. 148, no 3, p. 485\u2013490, mars 2018, https:\/\/doi.org\/10.1016\/j.ygyno.2017.12.026.","DOI":"10.1016\/j.ygyno.2017.12.026"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820301578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820301578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:48:16Z","timestamp":1758772096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825820301578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0090825820301578"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.02.021","relation":{},"ISSN":["0090-8258"],"issn-type":[{"type":"print","value":"0090-8258"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymph node metastasis probability in young patients eligible for conservative management of endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}